NCT07596992Not yet recruiting
Effects of Royal Jelly and Propolis on Metabolomic Signatures, Inflammation, and Cardiovascular Risk in Patients With Coronary Artery Disease.
Source: ClinicalTrials.gov · Last updated 19 May 2026
Brief summary (registry, in English)
The aim of this project is to evaluate the effect of bioactive compound sources, propolis and royal jelly, on metabolomics, inflammation, and cardiovascular risk markers in participants with coronary artery disease. A longitudinal double-blind randomized clinical trial will be carried out, involving CAD participants for two months.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 50 (estimated)
- First submitted
- 12 May 2026
- Start date
- 18 May 2026
- Primary completion date
- 31 Dec 2027
- Lead sponsor
- Universidade Federal Fluminense
- Diseases
- Coronary artery disease
- NCT number
- NCT07596992
What you commit to
- Study type: Interventional
- Planned participants: 50
- From 18 May 2026 to the primary completion date, 31 Dec 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Unstable Coronary Artery Disease;
- Unstable angina;
- Individuals with autoimmune diseases.
Lab values
- Advanced chronic kidney disease (creatinine clearance \< 30 ml/min/1.73 m²);
Other
- Pre-operative coronary artery bypass grafting or awaiting elective angioplasty;
- NYHA functional class III or higher;
Who the study is looking for
- Both sexes
- Over 18 years of age;
- Diagnosed with Coronary Artery Disease: confirmed by coronary angiography, coronary computed tomography angiography, or functional testing with ischemic load);
- Participants who are asymptomatic or have angina limited to functional class III will be considered;
- Patients who have already undergone coronary revascularization and angioplasty may participate;
- the last acute coronary event must have occurred more than one year ago.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Denise mafra Coordinator of this site? Confirm its status | Niterói | Brazil | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.